Actavis PLC : * To acquire auden mckenzie for 306 million gbp * Says Auden Mckenzie will be acquired on a debt free basis, and the transaction will exclude auden mckenzie's real estate portfolio * Deal includes two-year royalty on a percentage of gross profits of one of auden mckenzie's products * Says deal mmediately accretive to Actavis non-GAAP earnings * Says deal adds about 175 marketed products; pipeline of about 40 products * Says "acquisition will make Actavis the number one supplier of generic pharmaceuticals in the UK" * Source text for Eikon * Further company coverage
Shares of ACT traded higher by 0.4% or $1.11/share to $279.12. In the past year, the shares have traded as low as $174.94 and as high as $280.24. On average, 2975810 shares of ACT exchange hands on a given day and today's volume is recorded at 2716568.
Source
